Table of Contents >> Show >> Hide
If you’ve ever Googled “Fasenra” and immediately got hit with a wall of medical jargon, you’re not alone.
Benralizumab (brand name: Fasenra) is a prescription biologic used for certain severe asthma cases
and (more recently) for a specific form of vasculitis called EGPA. This FAQ-style guide breaks down what it is,
who it’s for, how it’s taken, what to watch for, and what day-to-day life with it can look likewithout making you
feel like you need a PhD just to breathe confidently.
Quick note: This article is for education only and isn’t medical advice. If you have symptoms of a severe
allergic reaction or an asthma emergency, seek urgent medical care right away.
Fasenra 101
What is benralizumab (Fasenra)?
Benralizumab is a biologic medicine (a type of monoclonal antibody) given as a
subcutaneous injection (under the skin). It’s used as an add-on maintenance treatment
for severe asthma with an eosinophilic phenotype in adults and children aged 6 and older, and it’s also
approved for treating adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
What does “eosinophilic asthma” mean?
Eosinophilic asthma is a form of asthma where eosinophils (a type of white blood cell involved in
inflammation) tend to be elevated and contribute to airway inflammation. Not everyone with asthma has this pattern,
which is one reason severe asthma often requires “phenotyping” (figuring out what’s driving it) before choosing a biologic.
How does Fasenra work?
Fasenra targets the IL-5 receptor alpha (IL-5Rα) found on eosinophils (and basophils). In simple terms:
it helps your immune system reduce eosinophils. In the prescribing information, benralizumab is described as
binding IL-5Rα and promoting eosinophil depletion through a process called antibody-dependent cell-mediated cytotoxicity (ADCC).
Translation: it flags eosinophils so immune “cleanup” cells can remove them more effectively. The label also notes that
the full mechanism in asthma and EGPA isn’t definitively established.
Is Fasenra a steroid or an inhaler?
Nope. Fasenra is not a steroid and it’s not a rescue inhaler. It’s a maintenance biologic.
Many people who start it are already using controller medications (like inhaled corticosteroids and long-acting bronchodilators).
Does Fasenra treat sudden asthma attacks?
No. Fasenra is not for acute bronchospasm or status asthmaticus (severe attacks).
If symptoms suddenly worsen, you still need your rescue plan and medical guidance.
Who Might Benefit
Who is Fasenra for?
Fasenra is generally considered when someone has severe asthma that remains poorly controlled despite
guideline-directed therapy, and testing suggests an eosinophilic/Type 2 inflammatory pattern.
Clinicians often use blood eosinophil counts and clinical history (like frequent exacerbations) to guide selection.
Do I need a specific eosinophil number?
Your clinician decides eligibility based on the big picture (symptoms, exacerbations, meds, test results).
Research summaries discuss using blood eosinophil thresholds (for example, 150 or 300 cells/µL) as guides in studies,
but real-world prescribing focuses on the overall “eosinophilic phenotype,” not a single magic number.
How old do you have to be to take Fasenra for asthma?
In the U.S., Fasenra is indicated for severe eosinophilic asthma in adults and pediatric patients aged 6 years and older.
What is EGPA, and why is Fasenra used for it?
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of vasculitis (blood vessel inflammation)
that often involves asthma/allergies and can affect multiple organs. Fasenra received U.S. marketing approval for
adult EGPA in September 2024. EGPA is complex and typically managed by specialists (often rheumatology and pulmonology).
Dosing and Schedule
How often is Fasenra given for asthma?
For many patients aged 12 and older, the schedule is every 4 weeks for the first 3 doses,
then every 8 weeks after that. (People often call the first three doses “starter” or “loading” doses.)
Is dosing different for children ages 6–11?
Yes. Pediatric dosing can depend on weight. In U.S. prescribing information, children ages 6–11 may receive
a different dose if they weigh under a certain threshold.
That’s one reason pediatric asthma specialists double-check the details and the device choice.
How often is Fasenra given for EGPA?
For EGPA, the recommended schedule is typically 30 mg every 4 weeks (adult patients).
What happens if I miss a dose?
The usual guidance is: take the missed dose as soon as possible and then continue the regular schedule.
Don’t double up unless your prescriber specifically tells you to. If you’re using a calendar reminder, this is where it pays off.
How quickly does Fasenra start working?
Biologics aren’t instant like a rescue inhaler. In clinical pharmacology data, eosinophils can drop quickly after dosing
and remain very low during treatment, but symptom improvement varies. Many clinicians reassess after a few months to see
whether exacerbations, steroid needs, or day-to-day control are improving.
Administration and Practical Use
Is Fasenra a shot? Where do you inject it?
YesFasenra is an injection under the skin. Common injection sites are the thigh or abdomen. If a caregiver gives it,
the upper arm may also be used. Most people rotate sites to reduce irritation (think: “don’t keep poking the same patch of real estate”).
What’s the difference between the prefilled syringe and the Fasenra Pen?
Fasenra is available as a prefilled syringe (often administered in a clinic) and as an autoinjector-style pen for at-home use
in appropriate patients. Your care team decides what’s safest and simplest for you.
How do I store Fasenra?
Storage matters because biologics are pickykind of like ice cream, but with higher stakes. Common guidance includes
storing it in the refrigerator in its original carton and allowing it to reach room temperature before use.
Fasenra may be kept at room temperature (typically 68°F to 77°F) for a limited time (commonly up to 14 days);
after that window, it should be used or discarded according to instructions.
How should I dispose of used pens/syringes?
Used needles and pens belong in a sharps containernot the household trash, not recycling,
and definitely not the “I’ll deal with it later” drawer. The FDA recommends placing used sharps immediately into a
proper sharps disposal container and following local disposal rules.
Safety and Side Effects
What are the most common side effects?
In asthma trials, commonly reported side effects included headache and pharyngitis (sore throat),
among others listed in prescribing information. Any medication can affect people differently, so report new or concerning symptoms to your clinician.
Can Fasenra cause allergic reactions?
Yes. Hypersensitivity reactions (including serious reactions like anaphylaxis) have been reported.
They may happen within hours, but delayed reactions (days later) are also described.
If a hypersensitivity reaction occurs, the prescribing information says Fasenra should be discontinued and patients should seek medical care.
Does Fasenra increase infection risk?
Fasenra targets eosinophils, which can play a role in immune responses. One specific warning involves
parasitic (helminth) infections: people with known helminth infections should be treated before starting,
and if infection occurs and doesn’t respond to treatment, Fasenra may be stopped until it resolves.
For everyday infections (like colds), your care team can advise you based on your history and risk factors.
Should I stop my inhaled steroids if I start Fasenra?
Don’t stop steroid medicines abruptly. The prescribing information warns against suddenly discontinuing systemic
or inhaled corticosteroids when starting Fasenra; if steroid doses are reduced, it should be done gradually under medical supervision.
Are there drug interactions with Fasenra?
Ask your clinician or pharmacist to review your medication list. The prescribing information includes a drug interaction section,
and your care team will consider your specific medications, including other immune-modifying therapies.
What about vaccines?
Vaccine timing is a common practical question for people on biologics. The best plan depends on your situation,
what vaccine you’re getting, and how stable your asthma/EGPA is. Bring it up earlyideally before “Oops, I got my shot tomorrow.”
Is Fasenra safe during pregnancy or breastfeeding?
Pregnancy and breastfeeding decisions require individualized medical guidance. For breastfeeding specifically, LactMed notes
that clinical data are limited; because benralizumab is a large protein molecule, amounts in breast milk are expected to be low and absorption by the infant is likely minimal,
but caution is still advisedespecially for newborns or preterm infantsuntil more data are available.
Effectiveness and What to Expect
What benefits do people usually hope for?
For severe eosinophilic asthma, the major goals often include fewer exacerbations (flare-ups), fewer emergency visits,
improved breathing and symptom control, and (in some cases) reduced reliance on oral corticosteroids.
In the U.S. label, pivotal trials for asthma include SIROCCO and CALIMA, and an oral corticosteroid reduction trial called ZONDA.
How does my clinician decide if it’s “working”?
“Working” usually isn’t one single number. Many clinicians look at:
- How often you’ve had exacerbations since starting
- Whether you need fewer oral steroids
- Changes in symptoms, rescue inhaler use, and activity tolerance
- Lung function testing when appropriate
- Overall quality of life (the underrated metric)
It’s also common to reassess adherence, triggers, and comorbiditiesbecause even a great biologic can’t outwork
daily exposure to a trigger you didn’t know you had.
Cost, Coverage, and Access
Is Fasenra expensive? How do people pay for it?
Biologics can be costly, and coverage varies by insurance plan. Many patients go through prior authorization.
The manufacturer also describes support programs that may help eligible patients understand coverage and affordability options.
If you’re navigating insurance paperwork, you have my full respectit’s basically an extreme sport.
What paperwork should I expect?
Common steps include benefits verification, prior authorization, and sometimes proof of severity or previous treatment attempts.
Clinics often have staff who handle this process regularly, which is goodbecause none of us should need a minor in “Insurance Studies.”
How to Talk About Fasenra With Your Care Team
What questions should I ask at my appointment?
- What type of severe asthma do I have (eosinophilic, allergic, both, or something else)?
- What goals are we targetingfewer exacerbations, less steroid use, better daily control?
- What’s my dosing schedule, and what’s the plan if I miss a dose?
- Should I get the injection in-office or at home? Which device is best for me?
- What side effects should I watch for, and when should I seek urgent care?
- How will we measure success at 3–6 months?
What’s a simple way to track progress?
Try a short weekly note (phone notes count as “a system”):
symptoms, rescue inhaler use, sleep, activity limits,
and any flare-ups. Bring that to follow-ups. It’s like giving your clinician a highlight reel instead of a mystery novel.
Real-World Experiences and Tips (About )
Beyond the clinical-trial language and official dosing schedules, people often want the practical stuff:
“What does this actually feel like in real life?” Everyone’s experience is different, but some themes show up again and again in
patient conversations and clinic routines.
1) The schedule can be surprisingly “life-friendly.” Many people appreciate that after the first three doses,
the maintenance interval can be every eight weeks for asthma. That longer spacing can make it easier to plan around school,
work, sports, travel, and just…being a human with a calendar. The flip side is that people sometimes forget it’s coming
(because eight weeks is long enough to forget where you put your favorite hoodie). Setting phone reminders and tying doses
to a recurring eventlike “the week after payday” or “every other report card”can reduce missed-dose stress.
2) The first few weeks can feel anticlimacticand that’s normal. Some patients expect a dramatic overnight
transformation. More often, improvements show up as fewer “bad days,” fewer flare-ups, and less panic about the next attack.
It can be subtle: you realize you climbed stairs without planning a rest stop, or you went a full week without thinking about
where your rescue inhaler is. Those small wins matter.
3) Injection-day routines help. People who do at-home injections often build a mini ritual: take the pen out
to warm to room temperature, clean a spot, inject, dispose in a sharps container, then do something pleasant (snack, show,
playlist). Not because the medicine needs a celebrationbecause you do. Making it routine reduces anxiety and
makes it less likely you’ll procrastinate.
4) Side effects are usually “annoying,” but the fear is the big thing to manage. Many people report mild effects
like headache or sore throat-type symptoms, and then spend more energy worrying about what those symptoms “mean” than
the symptoms themselves. A clear plan helps: know which symptoms are expected, which are concerning, and what to do.
The rare-but-serious concern that tends to stick in people’s heads is allergic reaction. It’s smart to ask your clinician
what warning signs to watch for and when to seek urgent helpthen try not to let that worry run your life.
5) Insurance navigation can be the hardest part. Real talk: the medicine may be simpler than the billing.
People often describe a phase of paperwork, prior authorizations, phone calls, and waiting for shipment coordination.
The most helpful “experience tip” is to keep a small folder (digital or paper) with key info: dates of exacerbations,
prior medications tried, lab results if provided, and contact numbers for the clinic and specialty pharmacy.
It’s not funbut it makes the process less chaotic.
6) Success isn’t always “perfect breathing.” For severe asthma or EGPA, a major win may be fewer steroids,
fewer flares, fewer missed school/work days, and less fear. If you’re tracking progress, celebrate improvements that
match your real life: sleeping through the night, exercising without symptoms, or not needing emergency care.
Those are meaningful outcomes, even if you still have occasional symptoms.
Conclusion
Benralizumab (Fasenra) is a targeted biologic option for severe eosinophilic asthma (age 6+) and adult EGPA.
The key idea is precision: it’s designed for specific inflammatory patterns, with dosing schedules that can be manageable
and goals that go beyond “feel better” to measurable reductions in exacerbations and steroid burden.
If you’re considering it, the best next step is a detailed conversation with your care team about your asthma/EGPA phenotype,
your treatment history, your risks, and how you’ll track whether it’s working.
